Melioidosis and leptospirosis are two emerging tropical infections that share somewhat similar clinical manifestations but require different methods of management. A 59-year-old farmer presented to a tertiary care hospital with an acute febrile illness associated with arthralgia, myalgia and jaundice, complicated by oliguric acute kidney injury and pulmonary haemorrhage. Treatment was initiated for complicated leptospirosis but with poor response. Blood culture was positive for Burkholderia pseudomallei and microscopic agglutination test (MAT) for leptospirosis was positive at the highest titres of 1:2560, confirming a co-infection of leptospirosis and melioidosis. The patient made a complete recovery with therapeutic plasma exchange (TPE), intermittent haemodialysis and intravenous (IV) antibiotics. Similar environmental conditions harbour melioidosis and leptospirosis, making co-infection a very real possibility. Co-infection should be suspected in patients from endemic areas with water and soil exposure. Using two antibiotics to cover both pathogens effectively is prudent. IV penicillin with IV ceftazidime is one such effective combination.
WiersingaWJCurrieBJPeacockSJ. Melioidosis. N Engl J Med2012; 367: 1035–1044.
5.
AldhousP. Tropical medicine: melioidosis? Never heard of it…Nature2005; 434: 692–694.
6.
CurrieBJDanceDAChengAC. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg2008; 102: S1–S4.
7.
DennyCRNichollsL. Melioidosis in a European. Ceylon J Sci1927; 2: 37–40.
8.
PeetermansWEVan WijngaerdenEVan EldereJ,et al.Melioidosis brain and lung abscess after travel to Sri Lanka. Clin Infect Dis1999; 28: 921–922.
9.
CoreaEMDe SilvaADThevanesamV. Melioidosis in Sri Lanka. Trop Med Infect Dis2018; 3: 22.
10.
JayasekaraKPereraSWijesundereA. Fatal Burkholderia pseudomallei septicaemia. Ceylon Med J2006; 51: 69–70.
11.
VincentATSchiettekatteOGoarantC, et al.Revisiting the taxonomy and evolution of pathogenicity of the genus Leptospira through the prism of genomics. PLoS Negl Trop Dis2019; 13: e0007270.
12.
CostaFHaganJECalcagnoJ, et al.Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis2015; 9: e0003898.
13.
WarnasekaraJKoralegedaraIAgampodiS. Estimating the burden of leptospirosis in Sri Lanka; a systematic review. BMC Infect Dis2019; 19: 1–12.
14.
WarnasekaraJNAgampodiS. Leptospirosis in Sri Lanka. Sri Lankan J Infect Dis2017; 15;7: 67.
15.
RajapakseSRodrigoCBalajiK,et al.Atypical manifestations of leptospirosis. Trans R Soc Trop Med Hyg2015; 109: 294–302.
16.
AliMRSafieeAWThangarajahP, et al.Molecular detection of leptospirosis and melioidosis co-infection: a case report. J Infect Public Health2017; 10: 894–896.
17.
Md-LasimAMohd-TaibFSAbdul-HalimM,et al.Leptospirosis and coinfection: should we be concerned?Int J Environ Res Public Health2021; 18: 9411.
18.
ChenYSChenSCKaoCM,et al.Effects of soil pH, temperature and water content on the growth of Burkholderia pseudomallei. Folia Microbiol2003; 48: 253–256.
19.
IzurietaRGalwankarSClemA. Leptospirosis: the “mysterious” mimic.J Emerg Trauma Shock2008; 1: 21.
20.
AdlerB. Leptospira and leptospirosis. Heidelberg: Springer, 2015.
21.
DharakulTTassaneetrithepBTrakulsomboonS,et al.Phylogenetic analysis of Ara+ and Ara− Burkholderia pseudomallei isolates and development of a multiplex PCR procedure for rapid discrimination between the two biotypes. J Clin Microbiol1999; 37: 1906–1912.
22.
SanfordJP. Leptospirosis—time for a booster. N Engl J Med1984; 310: 524–525.
23.
VanascoNBSchmelingMFLottersbergerJ,et al.Clinical characteristics and risk factors of human leptospirosis in Argentina (1999–2005). Acta Trop2008; 107: 255–258.
24.
HinHSRamalingamRChunnKY,et al.Case report: fatal co-infection–melioidosis and leptospirosis. Am J Trop Med Hyg2012; 87: 737.
25.
CurrieBJWardLChengAC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year darwin prospective study. PLoS Negl Trop Dis2010; 4: e900.
26.
YeeKCLeeMKChuaCT,et al.Melioidosis, the great mimicker: a report of 10 cases from Malaysia. J Trop Med Hyg1988; 91: 249–254.
27.
GulatiUNanduriACJunejaP, et al.Case report: a fatal case of latent melioidosis activated by COVID-19. Am J Trop Med Hyg2022; 106: 1170.
28.
LuPLTsengSH. Fatal septicemic melioidosis in a young military person possibly co-infected with Leptospira interrogans and Orientia tsutsugamushi. Kaohsiung J Med Sci2005; 21: 173–178.
29.
KoponenMAZlockDPalmerDL,et al.Melioidosis: forgotten, but not gone!Arch Intern Med1991; 151: 605–608.
30.
ChodimellaUHoppesWLWhalenS,et al.Septicemia and suppuration in a Vietnam veteran. Hosp Pract1997; 32: 219–221.
31.
Brightman C. Melioidosis: the Vietnamese time bomb. Trends Urol. Men's Health 2020; 11(3): 30–32.
32.
CurrieBJFisherDAAnsteyNM,et al.Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg2000; 94: 301–304.
33.
AgampodiSBDahanayakaNJNöcklerK,et al.Redefining gold standard testing for diagnosing leptospirosis: further evidence from a well-characterized, flood-related outbreak in Sri Lanka. Am J Trop Med Hyg2016; 95: 531.
34.
NiloofaRFernandoNde SilvaNL, et al.Diagnosis of leptospirosis: comparison between microscopic agglutination test, IgM-ELISA and IgM rapid immunochromatography test. PloS one2015; 10: e0129236.
35.
DenipitiyaDTChandrasekharanNVAbeyewickremeW, et al.Application of a real time Polymerase Chain Reaction (PCR) assay for the early diagnosis of human leptospirosis in Sri Lanka. Biologicals2016; 44: 497–502.
KingsleyPVArunkumarGTipreM,et al.Pitfalls and optimal approaches to diagnose melioidosis. Asian Pac J Trop Med2016; 9: 515–524.
38.
MazeMJElrodMGBiggsHM, et al.Investigation of melioidosis using blood culture and indirect hemagglutination assay serology among patients with fever, northern Tanzania. Am J Trop Med Hyg2020; 103: 2510.
39.
HaaseABrennanMBarrettS, et al.Evaluation of PCR for diagnosis of melioidosis. J Clin Microbiol1998; 36: 1039–1041.
40.
Hoffmaster AR, AuCoin D, Baccam P, et al. Melioidosis diagnostic workshop, 2013. Emerg Infect Dis [Internet]. 2015; 21(2) [cited 5 Feb 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313648/.
41.
SeppänenPC. Melioidosis presenting as urinary tract infection in a previously healthy tourist. Scand J Infect Dis2000; 32: 92–93.
42.
PhetsouvanhRPhongmanySNewtonP, et al.Melioidosis and Pandora's box in the Lao People's Democratic Republic. Clin Infect Dis2001; 32: 653–654.
43.
SullivanRPMarshallCSAnsteyNM,et al.2020 Review and revision of the 2015 Darwin melioidosis treatment guideline; paradigm drift not shift. PLoS Negl Trop Dis2020; 14: e0008659.
44.
Empirical and prophylactic use of antimicrobials. National Guidelines 2016 [Internet]. The Sri Lanka College of Microbiologists in collaboration with other professional colleges in healthcare and the Ministry of Health, Nutrition and Indigenous Medicine. [cited 1 July 2021] Available from:http://slmicrobiology.lk/download/National-Antibiotic-Guidelines-2016-Web.pdf.
45.
SuputtamongkolYRajchanuwongAChaowagulW, et al.Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis. Clin Infect Dis1994; 19: 846–853.
46.
ChetchotisakdPChierakulWChaowagulW, et al.Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet2014; 383: 807–814.
47.
ChaowagulWSimpsonAJSuputtamongkolY,et al.A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin Infect Dis1999; 29: 375–380.
48.
ChaowagulWChierakulWSimpsonAJ, et al.Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis. Antimicrob Agents Chemother2005; 49: 4020–4025.
49.
ChaowagulW. Recent advances in the treatment of severe melioidosis. Acta Trop2000; 74: 133–137.
50.
RajchanuvongAChaowagulWSuputtamongkolY,et al.A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg1995; 89: 546–549.
51.
MurrayCKHospenthalDR. Determination of susceptibilities of 26 Leptospira sp. Serovars to 24 antimicrobial agents by a broth microdilution technique. Antimicrob Agents Chemother2004; 48: 4002–4005.
52.
MoonJEEllisMCGriffithME, et al.Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. Antimicrob Agents Chemother2006; 50: 1989–1992.
53.
AltDPZuernerRLBolinCA. Evaluation of antibiotics for treatment of cattle infected with Leptospira borgpetersenii serovar hardjo. J Am Vet Med Assoc2001; 219: 636–639.
54.
GriffithMEMoonJEJohnsonEN, et al.Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model. Antimicrob Agents Chemother2007; 51: 2615–2617.
55.
RessnerRAGriffithMEBeckiusML, et al.Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. Antimicrob Agents Chemother2008;52:2750–2754.
56.
TrivediSVVasavaAHBhatiaLC,et al.Plasma exchange with immunosuppression in pulmonary alveolar haemorrhage due to leptospirosis. Indian J Med Res2010; 131: 429.
57.
HerathNUluwattageWWeliwitiyaT, et al.Sequel and therapeutic modalities of leptospirosis associated severe pulmonary haemorrhagic syndrome (SPHS); a Sri Lankan experience. BMC Infect Dis2019; 19: 1–8.
58.
Fonseka CL and Lekamwasam S. Role of plasmapheresis and extracorporeal membrane oxygenation in the treatment of leptospirosis complicated with pulmonary hemorrhages. J Trop Med [Internet]. 2018 [cited 5 Feb 2023]; 2018: 4520185. Available from: https://pubmed.ncbi.nlm.nih.gov/30631369/.
